BlackRock Health Sciences Trust II (BMEZ) - Net Assets
Based on the latest financial reports, BlackRock Health Sciences Trust II (BMEZ) has net assets worth $768.57 Million USD as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($774.59 Million) and total liabilities ($6.03 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BMEZ tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $768.57 Million |
| % of Total Assets | 99.22% |
| Annual Growth Rate | -14.02% |
| 5-Year Change | 40.78% |
| 10-Year Change | N/A |
| Growth Volatility | 33.06 |
BlackRock Health Sciences Trust II - Net Assets Trend (2019–2024)
This chart illustrates how BlackRock Health Sciences Trust II's net assets have evolved over time, based on quarterly financial data. See BMEZ days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for BlackRock Health Sciences Trust II (2019–2024)
The table below shows the annual net assets of BlackRock Health Sciences Trust II from 2019 to 2024. For live valuation and market cap data, see BlackRock Health Sciences Trust II (BMEZ) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $768.57 Million | +30.68% |
| 2023-12-31 | $588.14 Million | -2.01% |
| 2022-12-31 | $600.20 Million | -4.09% |
| 2021-12-31 | $625.77 Million | +14.62% |
| 2020-12-31 | $545.94 Million | -66.63% |
| 2019-12-31 | $1.64 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to BlackRock Health Sciences Trust II's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 248.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $942.10 Million | 122.58% |
| Total Equity | $768.57 Million | 100.00% |
BlackRock Health Sciences Trust II Competitors by Market Cap
The table below lists competitors of BlackRock Health Sciences Trust II ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
YD More Investments Ltd
TA:MRIN
|
$895.17 Million |
|
Domino's Pizza Enterprises Limited
F:HQX
|
$895.36 Million |
|
Shanghai Urban Architecture Design Co. Ltd.
SHE:300983
|
$895.63 Million |
|
WCON Electronics (Guangdong) Co. Ltd. A
SHE:301328
|
$895.71 Million |
|
Akums Drugs and Pharmaceutical
NSE:AKUMS
|
$894.85 Million |
|
Drägerwerk AG & Co. KGaA (pref)
F:DRW3
|
$894.83 Million |
|
ALPHAMAB ONCOLO.DL-000002
F:3NK
|
$894.57 Million |
|
Zhongtong Bus Holding Co Ltd
SHE:000957
|
$894.50 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BlackRock Health Sciences Trust II's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 588,135,430 to 768,567,015, a change of 180,431,585 (30.7%).
- Net income of 23,454,787 contributed positively to equity growth.
- Dividend payments of 35,922,238 reduced retained earnings.
- Share repurchases of 29,532,715 reduced equity.
- Other factors increased equity by 222,431,751.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $23.45 Million | +3.05% |
| Dividends Paid | $35.92 Million | -4.67% |
| Share Repurchases | $29.53 Million | -3.84% |
| Other Changes | $222.43 Million | +28.94% |
| Total Change | $- | 30.68% |
Book Value vs Market Value Analysis
This analysis compares BlackRock Health Sciences Trust II's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.25x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.99x to 0.25x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $14.52 | $14.32 | x |
| 2020-12-31 | $26.83 | $14.32 | x |
| 2021-12-31 | $5.54 | $14.32 | x |
| 2022-12-31 | $47.61 | $14.32 | x |
| 2023-12-31 | $42.18 | $14.32 | x |
| 2024-12-31 | $57.98 | $14.32 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BlackRock Health Sciences Trust II utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 97.44%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.01x
- Recent ROE (3.05%) is below the historical average (3.51%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 6.92% | 99.57% | 0.07x | 1.06x | $-50.37 Million |
| 2020 | 2.63% | 1517.89% | 0.01x | 0.18x | $-222.81 Million |
| 2021 | 9.45% | 99.09% | 0.09x | 1.04x | $-3.46 Million |
| 2022 | -4.41% | 0.00% | -0.04x | 1.01x | $-86.49 Million |
| 2023 | 3.40% | 244.30% | 0.01x | 1.01x | $-38.80 Million |
| 2024 | 3.05% | 97.44% | 0.03x | 1.01x | $-53.40 Million |
Industry Comparison
This section compares BlackRock Health Sciences Trust II's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $1,333,904,128
- Average return on equity (ROE) among peers: -55.53%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BlackRock Health Sciences Trust II (BMEZ) | $768.57 Million | 6.92% | 0.01x | $895.02 Million |
| Acadian Asset Management Inc (AAMI) | $2.54 Billion | 1.01% | 2.37x | $1.86 Billion |
| AllianceBernstein Holding L.P. (AB) | $1.80 Billion | 9.30% | 0.00x | $3.35 Billion |
| Associated Capital Group Inc (AC) | $878.25 Million | 1.16% | 0.08x | $78.56 Million |
| Abrdn Emerging Markets Equity Income Fund Inc (AEF) | $112.30 Million | -188.33% | 0.07x | $265.69 Million |
| AgriFORCE Growing Systems Ltd (AGRI) | $10.54 Million | -122.10% | 1.07x | $194.14 Million |
| Alpha Compute Corp (ALP) | $106.97K | -295.88% | 0.61x | $5.62 Million |
| Alvarium Tiedemann Holdings Inc. (ALTI) | $75.99 Million | 5.18% | 0.76x | $316.62 Million |
| Affiliated Managers Group Inc (AMG) | $655.56 Million | 9.23% | 1.32x | $8.77 Billion |
| Ameriprise Financial Inc (AMP) | $6.70 Billion | 11.85% | 12.89x | $39.64 Billion |
| AMTD IDEA Group (AMTD) | $570.49 Million | 13.24% | 3.41x | $42.49 Million |
About BlackRock Health Sciences Trust II
BlackRock Health Sciences Trust II operates in various business sectors.